Stay updated on Pembrolizumab in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.

Latest updates to the Pembrolizumab in Glioblastoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.6%
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.2%
- Check34 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check48 days agoChange DetectedThe page has updated its status to 'Completed' and added specific dates for upcoming events in May 2025, while removing outdated information regarding previous statuses and estimated dates.SummaryDifference1%
- Check55 days agoChange DetectedDifference0.1%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.2%
Stay in the know with updates to Pembrolizumab in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.